İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2023 · article

Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study

ISSN0342-4642
YÖKSİS OpenAlex Açık erişim · hybrid Üst %1
Yıl2023
Atıf165OpenAlex
Atıf154Semantic Scholar · 16 etkili
Yüzdelik%99,8
FWCI23,991,00 = dünya ortalaması
Scopus (SJR)Q1
WoS (JCR)Q1

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıIntensive Care Medicine
  • Katalog eşleşmesi (ISSN)Intensive Care Medicine
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

PURPOSE: The incidence, patient features, risk factors and outcomes of surgery-associated postoperative acute kidney injury (PO-AKI) across different countries and health care systems is unclear. METHODS: We conducted an international prospective, observational, multi-center study in 30 countries in patients undergoing major surgery (> 2-h duration and postoperative intensive care unit (ICU) or high dependency unit admission). The primary endpoint was the occurrence of PO-AKI within 72 h of surgery defined by the Kidney Disease: Improving Global Outcomes (KDIGO) criteria. Secondary endpoints included PO-AKI severity and duration, use of renal replacement therapy (RRT), mortality, and ICU and hospital length of stay. RESULTS: We studied 10,568 patients and 1945 (18.4%) developed PO-AKI (1236 (63.5%) KDIGO stage 1500 (25.7%) KDIGO stage 2209 (10.7%) KDIGO stage 3). In 33.8% PO-AKI was persistent, and 170/1945 (8.7%) of patients with PO-AKI received RRT in the ICU. Patients with PO-AKI had greater ICU (6.3% vs. 0.7%) and hospital (8.6% vs. 1.4%) mortality, and longer ICU (median 2 (Q1-Q3, 1-3) days vs. 3 (Q1-Q3, 1-6) days) and hospital length of stay (median 14 (Q1-Q3, 9-24) days vs. 10 (Q1-Q3, 7-17) days). Risk factors for PO-AKI included older age, comorbidities (hypertension, diabetes, chronic kidney disease), type, duration and urgency of surgery as well as intraoperative vasopressors, and aminoglycosides administration. CONCLUSION: In a comprehensive multinational study, approximately one in five patients develop PO-AKI after major surgery. Increasing severity of PO-AKI is associated with a progressive increase in adverse outcomes. Our findings indicate that PO-AKI represents a significant burden for health care worldwide.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

165atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 32 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
  2. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
  3. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trial.Atıf 29 · OpenAlex
  4. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
  5. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
  6. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
  7. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
  8. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
  9. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS‑AKI trialAtıf 29 · OpenAlex
  10. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex

Yazarlar

59
  1. ZELİHA ASLI DEMİR 1
  2. MUKADDER ORHAN SUNGUR 2
  3. DEMET ALTUN BİNGÖL 3
  4. NUR CANBOLAT 4
  5. MÜŞERREF BERİL DİNÇER MUTLU 5
  6. SERAP AKTAŞ YILDIRIM 6
  7. MÜZEYYEN İYİGÜN 7
  8. DAVUD YAPICI 8
  9. LEVENT ÖZDEMİR 9
  10. ASLINUR SAGÜN 10
  11. NEVAL BOZTUĞ 11
  12. EMEL GÜNDÜZ 12
  13. DEMET LAFLI TUNAY 13
  14. DENİZ KARAKAYA 14
  15. BURHAN DOST 15
  16. ÖZGÜR KÖMÜRCÜ 16
  17. ÖZLEM KORKMAZ DİLMEN 17
  18. EREN FATMA AKÇIL 18
  19. YUSUF TUNALI 19
  20. GÜLAY OK 20
  21. EDA TOK ALSİNA 21
  22. NURCAN KIZILCIK 22
  23. ÖZNUR ŞEN 23
  24. KAMİL DARÇIN 24
  25. SEMRA UĞUR 25
  26. YAVUZ GÜRKAN 26
  27. KEMAL TOLGA SARAÇOĞLU 27
  28. NADİDE AYSUN POSTACI 28
  29. AYŞEGÜL ÖZGÖK 29
  30. ÜMİT KARADENİZ 30
  31. EDA BALCI 31
  32. NEVRİYE SALMAN SAĞLIK BİLİMLERİ ÜNİVERSİTESİ 32
  33. BEHİÇ GİRGİN 33
  34. ÖZLEM SAĞIR 34
  35. HAFİZE FİSUN DEMİR 35
  36. FATİH UGÜN 36
  37. HÜSEYİN İLKSEN TOPRAK 37
  38. MUSTAFA SONER ÖZCAN 38
  39. FİLİZ ALKAYA SOLMAZ 39
  40. MEHMET YILMAZ 40
  41. ÜMRAN KARACA 41
  42. SEVTAP HEKİMOĞLU ŞAHİN 42
  43. SÜHEYLA KARADAĞ ERKOÇ 43
  44. NESLİHAN ALKIŞ 44
  45. VOLKAN BAYTAŞ 45
  46. ENGİN ERTÜRK 46
  47. SEDAT SAYLAN KARADENİZ TEKNİK ÜNİVERSİTESİ 47
  48. ALİ AKDOĞAN 48
  49. ÖMER FARUK BORAN 49
  50. YAVUZ ORAK 50
  51. FEYZA ÇALIŞIR 51
  52. SİBEL BÜYÜKÇOBAN 52
  53. BAHAR KUVAKİ BALKAN 53
  54. SEDA CANSABUNCU 54
  55. SELCAN AKESEN 55
  56. SUNA GÖREN 56
  57. OSMAN ORMAN 57
  58. ÖZLEM ERSOY KARKA DÜZCE ÜNİVERSİTESİ 58
  59. TÜLAY ŞAHİN 59